Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:vadadustat
|
| gptkbp:approvalYear |
2023
|
| gptkbp:approvedBy |
gptkb:FDA
cats chronic kidney disease nonregenerative anemia |
| https://www.w3.org/2000/01/rdf-schema#label |
Varenzin-CA1
|
| gptkbp:indication |
treatment of anemia in cats with chronic kidney disease
|
| gptkbp:manufacturer |
gptkb:Akebia_Therapeutics
|
| gptkbp:mechanismOfAction |
HIF-PH inhibitor
|
| gptkbp:regulates |
erythropoiesis
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:bfsParent |
gptkb:Elanco_Animal_Health
|
| gptkbp:bfsLayer |
6
|